Anti-CATK/ CTSK/ CTS02 functional antibody

Anti-CATK/ CTSK/ CTS02 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CTSK/CTSK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T11388-Ab-1/ GM-Tg-hg-T11388-Ab-2Anti-Human CTSK monoclonal antibodyHuman
GM-Tg-rg-T11388-Ab-1/ GM-Tg-rg-T11388-Ab-2Anti-Rat CTSK monoclonal antibodyRat
GM-Tg-mg-T11388-Ab-1/ GM-Tg-mg-T11388-Ab-2Anti-Mouse CTSK monoclonal antibodyMouse
GM-Tg-cynog-T11388-Ab-1/ GM-Tg-cynog-T11388-Ab-2Anti-Cynomolgus/ Rhesus macaque CTSK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T11388-Ab-1/ GM-Tg-felg-T11388-Ab-2Anti-Feline CTSK monoclonal antibodyFeline
GM-Tg-cang-T11388-Ab-1/ GM-Tg-cang-T11388-Ab-2Anti-Canine CTSK monoclonal antibodyCanine
GM-Tg-bovg-T11388-Ab-1/ GM-Tg-bovg-T11388-Ab-2Anti-Bovine CTSK monoclonal antibodyBovine
GM-Tg-equg-T11388-Ab-1/ GM-Tg-equg-T11388-Ab-2Anti-Equine CTSK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T11388-Ab-1/ GM-Tg-hg-T11388-Ab-2; GM-Tg-rg-T11388-Ab-1/ GM-Tg-rg-T11388-Ab-2;
GM-Tg-mg-T11388-Ab-1/ GM-Tg-mg-T11388-Ab-2; GM-Tg-cynog-T11388-Ab-1/ GM-Tg-cynog-T11388-Ab-2;
GM-Tg-felg-T11388-Ab-1/ GM-Tg-felg-T11388-Ab-2; GM-Tg-cang-T11388-Ab-1/ GM-Tg-cang-T11388-Ab-2;
GM-Tg-bovg-T11388-Ab-1/ GM-Tg-bovg-T11388-Ab-2; GM-Tg-equg-T11388-Ab-1/ GM-Tg-equg-T11388-Ab-2
Products NameAnti-CTSK monoclonal antibody
Formatmab
Target NameCTSK
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CTSK benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T11388-Ag-1Recombinant multi-species CATK/ CTSK/ CTS02 protein
    ORF Viral VectorvGMLP002924human CTSK Lentivirus particle
    ORF Viral VectorpGMLP002924human CTSK Lentivirus plasmid
    ORF Viral VectorpGMLPm001954mouse Ctsk Lentivirus plasmid
    ORF Viral VectorvGMLPm001954mouse Ctsk Lentivirus particle


    Target information

    Target IDGM-T11388
    Target NameCTSK
    Gene ID1513,13038,29175,574112,608843,101093379,513038,100054991
    Gene Symbol and SynonymscatK,CTS02,CTSK,CTSO,CTSO1,CTSO2,MMS10-Q,Ms10q,PKND,PYCD
    Uniprot AccessionP43235,O35186,P61277,Q3ZKN1,Q5E968
    Uniprot Entry NameCATK_HUMAN,CATK_MACMU,CATK_RAT,CATK_CANLF,CATK_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000143387
    Target ClassificationN/A

    The target: CTSK, gene name: CTSK, also named as CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD. The protein encoded by this gene is a lysosomal cysteine proteinase involved in bone remodeling and resorption. This protein, which is a member of the peptidase C1 protein family, is predominantly expressed in osteoclasts. However, the encoded protein is also expressed in a significant fraction of human breast cancers, where it could contribute to tumor invasiveness. Mutations in this gene are the cause of pycnodysostosis, an autosomal recessive disease characterized by osteosclerosis and short stature. [provided by RefSeq, Apr 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.